The Patent Finder

Polypeptides Useful for Gene Editing and Methods of Use

Lifeedit, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2019/068079, filed Dec 20, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,188,018Polypeptides Useful for Gene Editing and Methods of Use
In force
 · High confidence
Life Edit Therapeutics, Inc.In force
High confidence
US 12,655,426Polypeptides Useful for Gene Editing and Methods of Use
In force
 · High confidence
Life Edit Therapeutics, Inc.In force
High confidence
Application 18/826,746Polypeptides Useful for Gene Editing and Methods of Use
Pending
Not granted
LifeEDIT Therapeutics, Inc.PendingNot granted
Application 18/960,883Polypeptides Useful for Gene Editing and Methods of Use
Pending
Not granted
Life Edit Therapeutics, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Lifeedit, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited